The phytoprotective agent sulforaphane prevents inflammatory degenerative diseases and age-related pathologies via Nrf2-mediated hormesis
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 163, 105283
Abstract
No abstract availableKeywords
Funding Information
- ExxonMobil Foundation
- Air Force Office of Scientific Research
This publication has 103 references indexed in Scilit:
- Targeting of Nrf2 induces DNA damage signaling and protects colonic epithelial cells from ionizing radiationProceedings of the National Academy of Sciences, 2012
- Sulforaphane prevention of diabetes-induced aortic damage was associated with the up-regulation of Nrf2 and its down-stream antioxidantsNutrition & Metabolism, 2012
- Dose-dependent effects of R-sulforaphane isothiocyanate on the biology of human mesenchymal stem cells, at dietary amounts, it promotes cell proliferation and reduces senescence and apoptosis, while at anti-cancer drug doses, it has a cytotoxic effectAGE, 2011
- Hormesis provides a generalized quantitative estimate of biological plasticityJournal of Cell Communication and Signaling, 2011
- When NRF2 Talks, Who's Listening?Antioxidants & Redox Signaling, 2010
- Nrf2: friend or foe for chemoprevention?Carcinogenesis, 2009
- Hormesis definedAgeing Research Reviews, 2008
- Nrf2-mediated protection against 6-hydroxydopamineBrain Research, 2007
- Radiobiological Basis of Low-Dose Irradiation in Prevention and Therapy of CancerDose-Response, 2007
- Expression of Nrf2 in Neurodegenerative DiseasesJournal of Neuropathology & Experimental Neurology, 2007